BioFerr 90 Dual-Iron ASCORBIC ACID ASCORBIC ACID IRON PENTACARBONYL FERROUS CATION DOCUSATE SODIUM DOCUSATE FERROUS GLUCONATE FERROUS CATION FOLIC ACID FOLIC ACID CYANOCOBALAMIN CYANOCOBALAMIN POVIDONES CROSCARMELLOSE SODIUM DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER TITANIUM DIOXIDE MAGNESIUM STEARATE FD&C YELLOW NO. 5 MAGNESIUM SILICATE FD&C BLUE NO. 1 POLYETHYLENE GLYCOLS VITAMIN A PALMITATE ETHYL VANILLIN modified rectangle F7
Drug Facts
Composition & Profile
Identifiers & Packaging
HOW SUPPLIED: BioFerr™ 90 ( NDC 44523-732-90) is a green, modified rectangle shaped, film-coated tablet, debossed with “F7” on one side and blank on the other, and packaged in bottles of 90.; BioFerr™ 90 90 mg Dual-Iron Tablets NDC 44523-732-90 BioFerr 90 Label
- HOW SUPPLIED: BioFerr™ 90 ( NDC 44523-732-90) is a green, modified rectangle shaped, film-coated tablet, debossed with “F7” on one side and blank on the other, and packaged in bottles of 90.
- BioFerr™ 90 90 mg Dual-Iron Tablets NDC 44523-732-90 BioFerr 90 Label
Overview
Each green film-coated tablet for oral administration contains:
Indications & Usage
: BioFerr™ 90 is indicated for the treatment of all anemias that are responsive to oral iron therapy. These include: hypochromic anemia associated with pregnancy, chronic and/or acute blood loss, metabolic disease, post-surgical convalescence, and dietary needs.
Dosage & Administration
One tablet daily or as directed by a physician. Do not chew tablet.
Warnings & Precautions
WARNING: Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemia where vitamin B 12 is deficient.
Boxed Warning
Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. KEEP THIS PRODUCT OUT OF THE REACH OF CHILDREN. In case of accidental overdose, call a doctor or poison control center immediately.
Contraindications
: Hypersensitivity to any of the ingredients. Hemolytic anemia, hemochromatosis, and hemosiderosis are contraindications to iron therapy.
Adverse Reactions
Adverse reactions with iron therapy may include GI irritation, constipation, diarrhea, nausea, vomiting, and dark stools. Adverse reactions with iron therapy are usually transient. Allergic sensitization has been reported following both oral and parenteral administration of folic acid.
Drug Interactions
Geriatric Use: Dosing for elderly patients should be administered with caution. Due to the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy, dosing should start at the lower end of the dosing range. DRUG INTERACTIONS: Prescriber should be aware of a number of iron/drug interactions, including antacids, tetracyclines, or fluoroquinolones.
Storage & Handling
STORAGE: Store at 20°C to 25°C (68°F to 77°F). Excursions permitted between 15°C and 30°C (between 59°F and 86°F). (See USP Controlled Room Temperature.)℃
Similar Drugs
Related medications based on brand, generic name, substance, active ingredients.